Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04331912
What this trial is testing

PFS and OS of Patients With Advanced Neuroendocrine Cancer (NEN) After Systemic Treatment

Who this might be right for
Neuroendocrine Tumors
University of Warmia and Mazury 100
Testing effectiveness (Phase 2)UnknownNCT04619537
What this trial is testing

A Trial of Anlotinib Combined With Docetaxel in Patients With Wild-type Advanced Non-squamous Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Shandong Cancer Hospital and Institute 42
Testing effectiveness (Phase 2)Study completedNCT00310037
What this trial is testing

Bortezomib After Combination Chemotherapy, Rituximab, and an Autologous Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
Alliance for Clinical Trials in Oncology 151
Testing effectiveness (Phase 2)Study completedNCT00703222
What this trial is testing

A Phase I/II Study Of Immunization With Lymphotactin And Interleukin 2 Gene Modified Neuroblastoma Tumor Cells

Who this might be right for
Neuroblastoma
Baylor College of Medicine 7
Testing effectiveness (Phase 2)Study completedNCT00059722
What this trial is testing

This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With NSCLC.

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Genzyme, a Sanofi Company 160
Testing effectiveness (Phase 2)Study completedNCT00005802
What this trial is testing

Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center
Not applicableUnknownNCT04758481
What this trial is testing

Consolidation Conventional Radiotherapy + Stereotactic Body Radiotherapy at 3 Months After First-line Chemotherapy in Stage IV Oligometastatic Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
University Hospital Ostrava 20
Not applicableEnrolling By InvitationNCT04356274
What this trial is testing

Local Participatory Systems Dynamics to Increase Reach of Evidence Based Addiction and Mental Health Care

Who this might be right for
PTSDDepressionAlcohol Use Disorder+1 more
Palo Alto Veterans Institute for Research 720
Not applicableEnded earlyNCT01722890
What this trial is testing

CharactHer. ICORG 12-09, V3

Who this might be right for
HER2-positive Breast CancerTNM Stage II-IV Breast Cancer
Cancer Trials Ireland 130
Large-scale testing (Phase 3)Looking for participantsNCT04019548
What this trial is testing

Assessment of Swallowing Function and Quality of Life in Oropharyngeal Cancer Patients Treated by Chemo-radiotherapy

Who this might be right for
Oropharyngeal Cancer
Jules Bordet Institute 110
Testing effectiveness (Phase 2)Looking for participantsNCT06057935
What this trial is testing

Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma

Who this might be right for
Malignant Peritoneal MesotheliomaPeritoneal MesotheliomaMesothelioma+2 more
Memorial Sloan Kettering Cancer Center 64
Testing effectiveness (Phase 2)Looking for participantsNCT06385990
What this trial is testing

Utidelone (UTD1) Plus Capecitabine in Non-pCR TNBC After Neoadjuvant Therapy

Who this might be right for
Triple Negative Breast Neoplasms
Hunan Cancer Hospital 53
Not applicableStudy completedNCT02830282
What this trial is testing

Surveillance Markers of Utility for Recurrence After Neoadjuvant Chemotherapy for Breast Cancer

Who this might be right for
Breast Cancer
Abramson Cancer Center at Penn Medicine 21
Not applicableNot Yet RecruitingNCT07749924
What this trial is testing

Active Surveillance Versus Adjuvant Intravesical Chemotherapy in Liquid Biopsy-Defined Low-Shedding Intermediate-Risk NMIBC

Who this might be right for
Bladder CancerNon-Muscle-Invasive Bladder Cancer (NMIBC)
Tianjin Medical University Second Hospital 670
Post-approval studies (Phase 4)UnknownNCT05110417
What this trial is testing

Reversal of Botulinum Neurotoxin Injection Related Dysphonia With Pyridostigmine

Who this might be right for
Dysphonia, SpasticDysphoniaLaryngeal Dystonia
Eastern Virginia Medical School 10
Large-scale testing (Phase 3)UnknownNCT03992885
What this trial is testing

Clinical Study of Combination Therapy With Ectiecinib, Pemetrexed and Platinum in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer With EGFR Mutations.

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 70
Testing effectiveness (Phase 2)Looking for participantsNCT06904235
What this trial is testing

Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)

Who this might be right for
Nausea and Vomiting Chemotherapy-InducedNausea Post Chemotherapy
Helsinn Healthcare SA 95
Testing effectiveness (Phase 2)Looking for participantsNCT07113613
What this trial is testing

Prospective Study on Exemption of Tumor Bed Boost Radiotherapy for pCR Patients After Breast Conserving Surgery With Neoadjuvant Therapy

Who this might be right for
Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 150
Early research (Phase 1)Study completedNCT02048384
What this trial is testing

Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 22
Large-scale testing (Phase 3)Not Yet RecruitingNCT04736589
What this trial is testing

Inetetamab Plus Rapamycin and Chemotherapy for HER2+ Metastatic Breast Cancer With Abnormal Activation of PAM Pathway

Who this might be right for
Breast Cancer
Peking Union Medical College 270
Next Page